… spots so that the filaments are in a place to connect with the neurons and to fill the voids that we have. And I will say they expressed frustration that The FDA can be slow. They're in the process of approving. And one of the dynamics, China is rushing to develop this same technology. And China, the approvals are almost instantaneous. And the fda, it is very, very slow. (32:36–32:40)
CLAIM
Asserts that the FDA's approval process for Neuralink technology is slow.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
